Australian biotech market today 22.05.09

By Staff Writers
Friday, 22 May, 2009

As of 3.30pm, Healthcare index is down 1% on the back of a general 1.3% drop experienced by the All Ordinaries sparked by global economic concerns.

CSL dropped 50c to $30.90 and ResMed (ASX:RMD) is also down fractionally, along with the rest of the market.

Cochlear (ASX:COH) bucked the trend by rising $1.01 to $53.01, as did Ramsay Health Care (ASX:RHC), which gained 1.1%.

Ansell (ASX:ANN) shed 39 cents to $8.21 after Barclays Group issued a notice of ceasing to be a substantial holder from 18 May.

Related News

Less penicillin needed to treat Strep A infection than we thought

It's never been known exactly how much penicillin prevents sore throats — the most...

Stress disrupts emotion control in mental illness

Acute stress may impair key brain functions involved in managing emotions — particularly in...

Organoid platform enables closer study of bat-borne viruses

Reconstructing bat organ physiology in the lab lets scientists explore how zoonotic viruses work...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd